BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16043992)

  • 41. IL-12 receptor deficiency revisited: IL-23-mediated signaling is also impaired in human genetic IL-12 receptor beta1 deficiency.
    Hoeve MA; de Boer T; Langenberg DM; Sanal O; Verreck FA; Ottenhoff TH
    Eur J Immunol; 2003 Dec; 33(12):3393-7. PubMed ID: 14635048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor.
    Wada Y; Lu R; Zhou D; Chu J; Przewloka T; Zhang S; Li L; Wu Y; Qin J; Balasubramanyam V; Barsoum J; Ono M
    Blood; 2007 Feb; 109(3):1156-64. PubMed ID: 17053051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27.
    Beadling C; Slifka MK
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):15-24. PubMed ID: 16642253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae.
    Happel KI; Dubin PJ; Zheng M; Ghilardi N; Lockhart C; Quinton LJ; Odden AR; Shellito JE; Bagby GJ; Nelson S; Kolls JK
    J Exp Med; 2005 Sep; 202(6):761-9. PubMed ID: 16157683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility.
    Andersson A; Kokkola R; Wefer J; Erlandsson-Harris H; Harris RA
    J Leukoc Biol; 2004 Dec; 76(6):1118-24. PubMed ID: 15371491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The biology of IL-12: coordinating innate and adaptive immune responses.
    Watford WT; Moriguchi M; Morinobu A; O'Shea JJ
    Cytokine Growth Factor Rev; 2003 Oct; 14(5):361-8. PubMed ID: 12948519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-23: changing the verdict on IL-12 function in inflammation and autoimmunity.
    Kreymborg K; Böhlmann U; Becher B
    Expert Opin Ther Targets; 2005 Dec; 9(6):1123-36. PubMed ID: 16300465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells.
    Wurster AL; Rodgers VL; Satoskar AR; Whitters MJ; Young DA; Collins M; Grusby MJ
    J Exp Med; 2002 Oct; 196(7):969-77. PubMed ID: 12370258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses.
    Gately MK; Renzetti LM; Magram J; Stern AS; Adorini L; Gubler U; Presky DH
    Annu Rev Immunol; 1998; 16():495-521. PubMed ID: 9597139
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells.
    Nakamura T; Kamogawa Y; Bottomly K; Flavell RA
    J Immunol; 1997 Feb; 158(3):1085-94. PubMed ID: 9013946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis.
    Wang X; Zheng XY; Ma C; Wang XK; Wu J; Adem A; Zhu J; Zhang HL
    Scand J Immunol; 2014 Sep; 80(3):180-90. PubMed ID: 24910360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The immunobiology of IL-27.
    Hall AO; Silver JS; Hunter CA
    Adv Immunol; 2012; 115():1-44. PubMed ID: 22608254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of immune responses by interleukin-27.
    Yoshida H; Miyazaki Y
    Immunol Rev; 2008 Dec; 226():234-47. PubMed ID: 19161428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokine production by dendritic cells genetically engineered to express IL-4: induction of Th2 responses and differential regulation of IL-12 and IL-23 synthesis.
    Morita Y; Gupta R; Seidl KM; McDonagh KT; Fox DA
    J Gene Med; 2005 Jul; 7(7):869-77. PubMed ID: 15712252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoimmunity: A case of mistaken identity.
    Watford WT; O'Shea JJ
    Nature; 2003 Feb; 421(6924):706-8. PubMed ID: 12610607
    [No Abstract]   [Full Text] [Related]  

  • 56. Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy.
    Bowman EP; Chackerian AA; Cua DJ
    Curr Opin Infect Dis; 2006 Jun; 19(3):245-52. PubMed ID: 16645485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-18.
    Dinarello CA
    Methods; 1999 Sep; 19(1):121-32. PubMed ID: 10525448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology.
    Uhlig HH; McKenzie BS; Hue S; Thompson C; Joyce-Shaikh B; Stepankova R; Robinson N; Buonocore S; Tlaskalova-Hogenova H; Cua DJ; Powrie F
    Immunity; 2006 Aug; 25(2):309-18. PubMed ID: 16919486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis.
    Krajina T; Leithäuser F; Möller P; Trobonjaca Z; Reimann J
    Eur J Immunol; 2003 Apr; 33(4):1073-83. PubMed ID: 12672074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin-23: a key cytokine in inflammatory diseases.
    Duvallet E; Semerano L; Assier E; Falgarone G; Boissier MC
    Ann Med; 2011 Nov; 43(7):503-11. PubMed ID: 21585245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.